EUVIMEDEUVIMED entdecken
Crossref

LC-MS Analysis of Ginsenosides in Different Parts of Panax quinquefolius and Their Potential for Coronary Disease Improvement

Xuanming Zhang iD, Can Kong, Xixin Wang iD, Hairong Hou, Hongxia Yu, Lizhen Wang, Peihai Li, Xiaobin Li, Yun Zhang, Liwen Han, Kechun Liu

Planta Medica · 01.06.2023 · 89 (07) · 764-772

DOI: 10.1055/a-2058-1199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.06.2023. Verfasst von Xuanming Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening, Biology Institute, Qilu University of Technology (Shandong Aca…. Hauptthemen laut MEDLINE: Ginsenosides, Coronary Artery Disease, Panax. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Seven main ginsenosides, including ginsenoside Re, ginsenoside Rb1, pseudoginsenoside F11, ginsenoside Rb2, ginsenoside Rb3, ginsenoside Rd, and ginsenoside F2, were identified by LC-QTOF MS/MS from root, leaf and flower extracts of Panax quinquefolius. These extracts promoted intersegmental vessel growth in a zebrafish model, indicating their potential cardiovascular health benefits. Network pharmacology analysis was then conducted to reveal the potential mechanisms of ginsenoside activity in the treatment of coronary artery disease. GO and KEGG enrichment analyses elucidated that G protein-coupled receptors played a critical role in VEGF-mediated signal transduction and that the molecular pathways associated with ginsenoside activity are involved in neuroactive ligand–receptor interaction, cholesterol metabolism, the cGMP–PKG signaling pathway, etc. Moreover, VEGF, FGF2, and STAT3 were confirmed as the major targets inducing proliferation of endothelial cells and driving the pro-angiogenic process. Overall, ginsenosides could be potent nutraceutical agents that act to reduce the risks of cardiovascular disease. Our findings will provide a basis to utilize the whole P. quinquefolius plant in drugs and functional foods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GinsenosidesCoronary Artery DiseasePanaxAnimalsChromatography, LiquidTandem Mass SpectrometryChromatography, High Pressure LiquidEndothelial CellsVascular Endothelial Growth Factor AZebrafishPlant Extracts

Substanzen

GinsenosidesVascular Endothelial Growth Factor APlant Extracts

Autor:innen und Institutionen

  • Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening, Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China.
  • Wendeng Daodishen Industry Co. Ltd., Weihai, China.
  • College of Pharmacy and Pharmaceutical Sciences, Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan, China.

ORCID-Profile: Xuanming Zhang, Xixin Wang

Zitieren

APA

Zhang, X., Kong, C., Wang, X., Hou, H., Yu, H., Wang, L., Li, P., Li, X., Zhang, Y., Han, L., & Liu, K. (2023). LC-MS Analysis of Ginsenosides in Different Parts of Panax quinquefolius and Their Potential for Coronary Disease Improvement. Planta Medica, 89(07), 764-772. https://doi.org/10.1055/a-2058-1199

Vancouver

Zhang X, Kong C, Wang X, Hou H, Yu H, Wang L, et al. LC-MS Analysis of Ginsenosides in Different Parts of Panax quinquefolius and Their Potential for Coronary Disease Improvement. Planta Medica. 2023;89(07):764-772. doi:10.1055/a-2058-1199

BibTeX
@article{Zhang2023,
  author = {Zhang, Xuanming and Kong, Can and Wang, Xixin and Hou, Hairong and Yu, Hongxia and Wang, Lizhen and Li, Peihai and Li, Xiaobin and Zhang, Yun and Han, Liwen and Liu, Kechun},
  title = {LC-MS Analysis of Ginsenosides in Different Parts of Panax quinquefolius and Their Potential for Coronary Disease Improvement},
  journal = {Planta Medica},
  year = {2023},
  volume = {89},
  number = {07},
  pages = {764--772},
  doi = {10.1055/a-2058-1199}
}
Kostenlos starten →